| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −7.9× | −1.7× | |
| Price / Book | 3.9× | 2.0× | |
| Price / Sales | 18.0× | 3.9× | |
| Price / Free cash flow | −8.8× | −1.5× | |
| EV / EBITDA | −4.2× | −1.2× | |
| Earnings yield | −12.7% | −14.4% | |
| Free cash flow yield | −11.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,286.69 | +3.74% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.00 | +2.05% | $624.15B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $287.68 | +1.77% | $508.36B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.77 | +3.17% | $376.78B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.10 | +3.11% | $365.39B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.43 | +2.15% | $282.85B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.69 | +2.89% | $261.62B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $688.53 | +1.35% | $254.58B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $436.90 | +2.81% | $236.2B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.18 | +2.03% | $193.66B | 22.3× | 37.5% | +29.9% |
